Author:
Jaksha Alexandria F.,Weitzel Erik K.,Laury Adrienne M.
Abstract
Rhinosinusitis affects a significant portion of the US population, and its management imposes a substantial burden on the healthcare system. The treatment of chronic rhinosinusitis includes initial medical management prior to consideration of surgical intervention. However, if surgery does become necessary, several factors must be considered in order to optimize outcomes. This review evaluates surgical patient selection, perioperative medical management, and the extent of operative intervention, with the goal of improving surgical results, decreasing the need for revision surgery, and enhancing the patient’s quality of life. Specific variations in patient genotypes and phenotypes will be further explored with regard to their implications on surgical outcomes. Additionally, the evidence behind pre- and post-operative antibiotic and steroid use will be evaluated. Finally, we will review evolving surgical tools and techniques that are currently being utilized for the treatment of specific subsets of rhinosinusitis.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference61 articles.
1. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States.;N Bhattacharyya;Ann Otol Rhinol Laryngol.,2011
2. Summary health statistics for U.S. adults: National Health Interview Survey, 2009.;J Pleis;Vital Health Stat 10.,2010
3. Clinical practice guideline (update): Adult Sinusitis Executive Summary.;R Rosenfeld;Otolaryngol Head Neck Surg.,2015
4. Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study with 1-year follow-up.;T Smith;Int Forum Allergy Rhinol.,2013
5. European Position Paper on Rhinosinusitis and Nasal Polyps 2012.;W Fokkens;Rhinol Suppl.,2012
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献